Patent details
EP1423364
Title:
CRYSTALLINE FORMS OF ÖR-(R*,R*)Ü-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYLÜ-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
Basic Information
- Publication number:
- EP1423364
- PCT Application Number:
- PCT/IB/2002/001796
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP027279462
- PCT Publication Number:
- WO/2003/004470
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- CRYSTALLINE FORMS OF ÖR-(R*,R*)Ü-2-(4-FLUOROPHENYL)-BETA, DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-PHENYLAMINO)CARBONYLÜ-1H-PYRROLE-1-HEPTANOIC ACID CALCIUM SALT (2:1) (ATORVASTATIN)
- French Title of Invention:
- FORMES CRISTALLINES DE SEL HEMICALCIQUE (2:1) D'ACIDE ÖR-(R*,R*)Ü -2-(4-FLUOROPHENYL)-BETA,DELTA-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYL -1H-PYRROLE-1-HEPTANOIQUE (ATORVASTATINE)
- German Title of Invention:
- KRISTALLINE FORMEN DES CALCIUMSALZES (2:1) VON ÖR-(R*,R*)Ü-2-(4-FLUORPHENYL)-BETA, DELTA -DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-(PHENYLAMINO)CARBONYLÜ-1H-PYRROL-1-HEPTANSÄURE (ATORVASTATIN)
- SPC Number:
-
Dates
- Filing date:
- 21/05/2002
- Grant date:
- 04/11/2015
- EP Publication Date:
- 04/11/2015
- PCT Publication Date:
- 16/01/2003
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 02/06/2004
- EP B1 Publication Date:
- 04/11/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 21/05/2016
- Expiration date:
- 21/05/2022
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 21/05/2002
-
-
- Name:
- Warner-Lambert Company LLC
- Address:
- 235 East 42nd Street, New York, NY 10017, United States (US)
Inventor
1
- Name:
- MORRISON Henry Grant, II
- Address:
- United States (US)
2
- Name:
- LI Zheng J., Pfizer Global Research and Develop.
- Address:
- United States (US)
3
- Name:
- VLAHOVA Petinka Ivanova
- Address:
- United States (US)
4
- Name:
- BYRN Stephen Robert
- Address:
- United States (US)
5
- Name:
- PARK Aeri
- Address:
- United States (US)
6
- Name:
- COATES David Andrew
- Address:
- United States (US)
7
- Name:
- KRZYZANIAK J. F., Pfizer Global Researchand Dev.
- Address:
- United States (US)
8
- Name:
- GUSHURST Karen Sue
- Address:
- United States (US)
Priority
- Priority Number:
- 302049 P
- Priority Date:
- 29/06/2001
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
C07D 207/34;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
| Filing date |
Document type |
Number of pages |